InsiderClue
Insiders · Profile

Maynard Ryan D

Director at IOVANCE BIOTHERAPEUTICS · CHIEF FINANCIAL OFFICER at Tvardi Therapeutics · EVP & CFO at RIGEL PHARMACEUTICALS. Filing since 7 Aug 2012. CIK 0001363984

IOVA IOVANCE BIOTHERAPEUTICS, INC. Director · 2 trades TVRD Tvardi Therapeutics, Inc. CHIEF FINANCIAL OFFICER · 1 trade RIGL RIGEL PHARMACEUTICALS INC EVP & CFO · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IOVA IOVANCE BIOTHERAPEUTICS, INC.
12 Nov 2024
Director
Sold at will
50,000
$503.00K
87.0%
TVRD Tvardi Therapeutics, Inc.
8 Feb 2023
CHIEF FINANCIAL OFFICER
Sold on a plan
5,488
$2.91K
40.7%
IOVA IOVANCE BIOTHERAPEUTICS, INC.
31 May 2022
Director
Bought
7,500
$50.59K
opened
RIGL RIGEL PHARMACEUTICALS INC
3 Nov 2017
EVP & CFO
Sold, plan not stated
100,000
$390.00K
100%
RIGL RIGEL PHARMACEUTICALS INC
10 Sep 2012
EVP & CFO
Sold, plan not stated
17,586
$184.93K
100%
RIGL RIGEL PHARMACEUTICALS INC
7 Sep 2012
EVP & CFO
Sold, plan not stated
57,414
$608.52K
100%
RIGL RIGEL PHARMACEUTICALS INC
7 Aug 2012
EVP & CFO
Sold, plan not stated
1,700
$18.04K
100%
7 decisions on file.